GH 8-K 2026-11-03

Guardant Health, Inc. (GH) 8-K dated 2026-11-03 — accession 0001193125-26-445514.

Guardant Health, Inc. (GH) is a diagnostics & research company listed on US.

Guardant Health, Inc. filed a 8-K on 2026-11-03. Accession 0001193125-26-445514.

This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported GH revenue for 2025-12-31 was $982.0M. Net income was -$416.3M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. GH currently screens at market cap $6.32B.

Not investment advice. The GH SEC hub lists recent forms. The stock page is the research view.